China Biopharmaceuticals Holdings, Inc (Symbol: CHBP) is a
vertically integrated pharmaceutical company dedicated to the discovery,
development, manufacturing and marketing of small and large molecule
pharmaceutical products, including medicines, vaccines, and active
pharmaceutical ingredients for various categories of diseases.
CHBP's product portfolio includes 260 drugs already approved for
manufacturing and marketing by the Chinese State Food and Drug
Administration (SFDA). CHBP also has submitted 15 drug applications to
the SFDA for its review during the calendar year of 2006. CHBP is a
U.S.-listed public company with operating subsidiaries and senior
management based in China.
For more information, visit http://www.cbioinc.com or call
914/669-0222.
COPYRIGHT 2008 Worldwide
Videotex Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008, Gale Group. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.